Micro Emerging Active

BMY Camzyos Phase 3 試験の成功

New narrative with limited coverage — still forming.

スコア
0.4
勢い
▲ 1.0
記事
2
情報源
2

Sentiment Timeline

Event Timeline

4月 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
4月 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

タイムライン

初回検出4月 02, 2026
最終更新4月 02, 2026